Most companies underestimate how complex PRRC responsibilities really are under MDR and IVDR. On the surface, it seems straightforward—appoint a qualified person, document the role, and assume compliance is covered. But this assumption quickly turns into a problem. The PRRC responsibilities are not administrative—they include oversight of conformity assessment, technical documentation, post-market surveillance, and vigilance across the entire product lifecycle . When these responsibilities are not properly integrated into the organisation, gaps appear: documentation becomes inconsistent, regulatory control weakens, and audit findings start to accumulate. This is where the pressure escalates. Companies realise too late that appointing a PRRC is not enough—the system behind the role is what determines compliance. To avoid this risk, organisations must move from formal designation to structured implementation, where PRRC responsibilities are fully embedded into everyday regulatory operations.

What are PRRC responsibilities under MDR/IVDR—and why most companies get them wrong

At first glance, PRRC responsibilities seem clearly defined in Article 15 of MDR and IVDR. The role is designed to ensure that manufacturers maintain continuous compliance across the entire product lifecycle—from device release to post-market activities. But this clarity is misleading.

In reality, PRRC responsibilities are broad and deeply interconnected. The PRRC must ensure that conformity assessments are properly carried out, technical documentation is complete and continuously updated, and post-market surveillance and vigilance obligations are fulfilled. This includes verifying that devices meet regulatory requirements before release, overseeing safety reporting, and ensuring that all regulatory processes remain aligned over time.

The issue is not the definition—it is the implementation.

Most companies interpret PRRC responsibilities as a checklist instead of a control function. They assign accountability to one person without building the system that enables that person to actually oversee compliance. This creates a disconnect between responsibility and execution.

Regulators introduced the PRRC role specifically to close this gap—to ensure that compliance is not fragmented across departments, but centrally controlled by a qualified expert. Yet in practice, many organisations still operate in silos, where quality, regulatory, clinical, and vigilance activities are not fully aligned.

This is where things start to break down. Without integration into the quality management system and daily operations, PRRC responsibilities cannot be fulfilled effectively. Instead of acting as a safeguard, the role becomes a bottleneck—or worse, a false sense of compliance.

How Billev Pharma East takes control of your PRRC responsibilities- so you don’t have to

This is the point where most companies realise the truth: PRRC responsibilities cannot be managed effectively without a system behind them. And this is exactly where we step in.

At Billev Pharma East, we don’t just “provide a PRRC.” We take ownership of the entire regulatory structure that enables those responsibilities to work in practice. Our experts can act as your outsourced PRRC or integrate directly into your organisation—ensuring full compliance with MDR and IVDR requirements.

What makes the difference is how we connect everything the PRRC is accountable for. We align your quality management system, technical documentation, clinical evaluation, post-market surveillance, and vigilance into one controlled framework. This is not theoretical support—it is operational execution. Our services cover everything from MDR/IVDR gap analysis and QMS implementation to technical file preparation and ongoing vigilance oversight, ensuring that compliance is not fragmented across departments.

Instead of leaving your PRRC exposed, we build a structure where every responsibility is supported, traceable, and audit-ready. We also ensure continuous availability, clear escalation pathways, and full alignment with regulatory authorities across the EU.

The result is simple: your PRRC responsibilities are no longer a risk—they become a controlled, fully functional compliance system.

If you want to avoid regulatory gaps, delays, and audit findings, you don’t need another consultant. You need a partner who can take ownership. That is exactly what Billev Pharma East delivers.

How to structure PRRC responsibilities so they actually work in practice

Defining PRRC responsibilities is not about copying Article 15 into a job description—it is about translating regulatory obligations into a system that works in real operations.

Under MDR and IVDR, the PRRC is responsible for ensuring that conformity assessments are performed, technical documentation is maintained, and post-market surveillance and vigilance activities are continuously fulfilled. But these responsibilities only become meaningful when they are clearly embedded into processes, ownership, and decision-making flows.

This is where most companies fail. They define responsibilities at a high level but never connect them to actual workflows. As a result, the PRRC lacks visibility, control, and authority—making it impossible to verify compliance in real time.

A structured approach changes this completely.

First, every regulatory requirement must be mapped to a specific process. Device release, documentation updates, PMS activities, and vigilance reporting cannot exist as separate silos—they must be connected into one continuous lifecycle.

Second, responsibilities must be traceable. The PRRC should be able to verify not only that activities are performed, but also that they are documented, reviewed, and aligned with regulatory expectations.

Third, the PRRC must be positioned as a control function, not an executor. The role exists to ensure compliance across the system—not to compensate for missing processes or fragmented responsibilities.

When this structure is in place, PRRC responsibilities become a powerful mechanism for maintaining regulatory control. Without it, they remain theoretical—visible on paper, but ineffective in practice.

Where PRRC responsibilities fit within your overall regulatory system

One of the most overlooked aspects of PRRC responsibilities is how they fit into the broader regulatory and quality ecosystem. The role does not operate in isolation—it is positioned at the centre of the entire compliance structure defined by MDR and IVDR.

Under Article 15, the PRRC is directly linked to the manufacturer’s obligations under Article 10, meaning their responsibilities extend across quality management, product compliance, and post-market activities. This creates a critical dependency: the PRRC can only function effectively if the surrounding system—QMS, documentation, and reporting processes—is robust and interconnected.

In practice, this means the PRRC works closely with multiple roles. For example, while the quality management representative ensures that processes are implemented and maintained, the PRRC verifies that those processes actually meet regulatory requirements. This distinction is subtle but essential. One builds the system; the other ensures it complies with the law.

The same applies across the product lifecycle. From device release to post-market surveillance and vigilance reporting, the PRRC is responsible for oversight—not execution—but must still ensure that every activity meets regulatory expectations.

This interconnected position is exactly why the role is so powerful—and so often misunderstood.

When properly integrated, PRRC responsibilities act as a central control mechanism that connects quality, regulatory, and safety functions into one aligned system. Without that integration, the role becomes disconnected, reactive, and ultimately ineffective.

PRRC responsibilities are only as strong as the system behind them

The role of the PRRC was introduced by MDR and IVDR for a reason: to ensure continuous oversight and control of regulatory compliance across the entire product lifecycle. It is not optional, and it is not symbolic—it is a legally required function that directly impacts whether your products can remain on the EU market.

But here is the key takeaway: PRRC responsibilities do not create compliance on their own. They only work when they are supported by a structured, integrated system that allows the PRRC to verify, control, and intervene when needed. Without that, even a highly qualified PRRC cannot prevent gaps in documentation, PMS, or vigilance activities.

That is why companies that treat PRRC as a formal requirement often struggle—while those that build the right system around it achieve real regulatory control.

If you are facing MDR/IVDR pressure, audit risks, or uncertainty around how to operationalise PRRC responsibilities, this is exactly where the right partner makes the difference.

Billev Pharma East does not just help you meet the requirement—we ensure it works in practice. From acting as your PRRC to building the full regulatory and quality framework behind the role, we take ownership of your compliance so you can focus on your product and growth.

If you want PRRC responsibilities fully under control—not just on paper—it’s time to work with a partner who delivers exactly that.

Sources: 1 – European Commission. (2023). MDCG 2019-7 Rev.1: Guidance on Article 15 of MDR and IVDR regarding a person responsible for regulatory compliance (PRRC), 2 – Medical Device Coordination Group (MDCG). (2023). Guidance on PRRC under MDR/IVDR (Article 15), 3 – Mantra Systems. (n.d.). Person responsible for regulatory compliance (PRRC) under EU MDR, 4 – MedDeviceGuide. (2026). EU MDR PRRC: Person responsible for regulatory compliance explained, 5 – ohner Institute. (n.d.). PRRC under MDR and IVDR: Requirements and responsibilities.

Image credits:

In-article images: Pexels

Hero image: Pexels